Exploring the Feasibility and Acceptability of Virtual Reality Exercise for Pain Management, Fear of Movement, Mobility, and Proprioception Deficit in Axial Spondyloarthritis Patients During Flares: Twics Design

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Bath

About this trial

Axial spondyloarthritis (axSpA) is an autoimmune disease that causes inflammatory arthritis of the spine, causing pain, stiffness, and mobility limitations. During flares, when symptoms worsen, people with axSpA often experience increased pain and difficulty moving, making daily activities more challenging. This study aims to explore whether virtual reality (VR) exercise can help manage pain, improve movement, and support rehabilitation for axSpA patients during flares.

Participants will use a VR system to perform gentle exercises designed to encourage movement and reduce discomfort. Their spinal mobility will be measured using motion capture technology, and their experiences with VR will be assessed through questionnaires and interviews.

This research will help determine whether VR can be a practical and beneficial tool for axSpA rehabilitation, potentially offering a new way to manage symptoms and improve quality of life. The findings will guide future studies on using VR in healthcare settings for people with chronic pain conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Confirmed diagnosis of axial spondyloarthritis (axSpA).

Experiencing an active flare of axSpA within the last 6 months

Over 18 years of age.

Disqualifiers

History of major spinal surgery.

Pregnancy.

Severe vestibular disorders, visual, balance, neurological, or cardiovascular conditions that may affect mobility.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual reality head set.

    Other intervention

    Tennis game exercise using virtual reality head set

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: control groupNo intervention 0 interventions
Group B: Virtual reality groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

1. Change in spinal mobility

Spinal mobility will be assessed using range of motion (ROM) measured via motion capture system.

Time frame
between baseline and one month follow up
2

Change in movement velocity

Movement velocity of spinal flexion, extension, and rotation will be measured using a motion capture system. Peak angular velocity (degrees/second) will be recorded during standardised movement tasks and compared between baseline and one-month follow-up. Unit of Measure: Degrees/second

Time frame
Baseline to one month follow up
3

Change in kinesiophobia

Kinesiophobia will be measured using the Tampa Scale of Kinesiophobia (TSK). The scale ranges from 17 to 68, with higher scores indicating greater fear of movement. Unit of Measure: TSK score (17-68; higher = worse)

Time frame
Baseline to one month follow up
4

Change in pain intensity

Pain intensity will be assessed using the Visual Analogue Scale (VAS). The scale ranges from 0 to 10, with higher scores indicating greater pain. Change from baseline to follow-up will be analysed. Unit of Measure: VAS score (0-10; higher = worse)

Time frame
Baseline to one month follow up

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: